EUVIMEDObjevte EUVIMED
Crossref

SGLT2 Inhibitors in Kidney Transplant Recipients: Promising Signals, But Limited Evidence

Jacek Kubica, Aldona Kubica

Clinical Diabetology · 2026-04-28

DOI: 10.5603/cd.112125 ↗

At a glance

Journal article in Clinical Diabetology, published online on 2026-04-28. Written by Jacek Kubica and 1 co-authors.

AbstraktBibliografické údajeCiteRelated studies

Abstract (original language)

Není k dispozici žádný abstrakt.

Cite

APA

Kubica, J., & Kubica, A. (2026). SGLT2 Inhibitors in Kidney Transplant Recipients: Promising Signals, But Limited Evidence. Clinical Diabetology. https://doi.org/10.5603/cd.112125

Vancouver

Kubica J, Kubica A. SGLT2 Inhibitors in Kidney Transplant Recipients: Promising Signals, But Limited Evidence. Clinical Diabetology. 2026. doi:10.5603/cd.112125

BibTeX
@article{Kubica2026,
  author = {Kubica, Jacek and Kubica, Aldona},
  title = {SGLT2 Inhibitors in Kidney Transplant Recipients: Promising Signals, But Limited Evidence},
  journal = {Clinical Diabetology},
  year = {2026},
  doi = {10.5603/cd.112125}
}
Start for free →